Abdominal organ transplantation

Minerva Anestesiologica

Volumn 76, Issue 4, 2010, Pages 266-275

  Niemann, C U ^a   Eilers, H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Kidney transplantation; Liver transplantation; Organ transplantation

Indexed keywords

DOBUTAMINE; DOPAMINE; FENOLDOPAM; FRESH FROZEN PLASMA; IMMUNOSUPPRESSIVE AGENT; LOOP DIURETIC AGENT; MANNITOL; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; THALLIUM;

ANGIOCARDIOGRAPHY; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CADAVER DONOR; CARDIOVASCULAR DISEASE; COLLOID; CORONARY ARTERY RECANALIZATION; CRYOPRECIPITATE; CRYSTALLOID; ECHOCARDIOGRAPHY; ERYTHROCYTE TRANSFUSION; FLUID THERAPY; HEART SCINTISCANNING; HEMODIALYSIS; HUMAN; INTENSIVE CARE; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; MEDICAL DOCUMENTATION; MEDICAL RESEARCH; MULTIDETECTOR COMPUTED TOMOGRAPHY; OVERALL SURVIVAL; PANCREAS INSUFFICIENCY; PANCREAS TRANSPLANTATION; PATIENT MONITORING; PATIENT SAFETY; PERITONEAL DIALYSIS; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; RENAL GRAFT DYSFUNCTION; REVIEW; RISK ASSESSMENT; STRESS ECHOCARDIOGRAPHY; SURGICAL TECHNIQUE; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME;

HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; PERIOPERATIVE CARE;

EID: 77950422160     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-9.
2. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-403.
3. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant 2007;7:2587-96.
4. Kim WR. The burden of hepatitis C in the United States. Hepatology 2002;36:S30-4.
5. Wiesner RH, Rakela J, Ishitani MB, Mulligan DC, Spivey JR, Steers JL et al. Recent advances in liver transplantation. Mayo Clin Proc 2003;78:197-210.
6. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999;341:1725-30.
7. OPTN - Organ Procurement and Transplantation Network [Homepage]. [cited 2009 October 27]. Available at: http://optn.transplant.hrsa.gov/
8. Ojo AO, Held PJ, Wolfe RA, Merion RM, Leichtman AB, Young EW et al. Trends in cadaveric organ donation in the United States: 1990-1999. Clin Transpl 2002;105-109.
9. Pilmore H. Cardiac assessment for renal transplantation. Am J Transplant 2006;6:659-65.
10. Herzog CA, Marwick TH, Pheley AM, White CW, Rao VK, Dick CD. Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis 1999;33:1080-90.
11. Rabbat CG, Treleaven DJ, Russell JD, Ludwin D, Cook DJ. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidneypancreas transplantation: a meta-analysis. J Am Soc Nephrol 2003;14:431-9.
12. De Lima JJ, Sabbaga E, Vieira ML, de Paula FJ, Ianhez LE, Krieger EM et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 2003;42:263-8.
13. Sun Z, Lin C, Davidson R, Dong C, Liao Y. Diagnostic value of 64- slice CT angiography in coronary artery disease: a systematic review. Eur J Radiol 2008;67:78-84.
14. Bastarrika G, Lee YS, Ruzsics B, Schoepf UJ. Coronary CT angiography: applications. Radiol Clin North Am 2009;47:91-107.
15. Burgstahler C, Beck T, Reimann A, Kuettner A, Kopp AF, Heuschmid M et al. Diagnostic accuracy of multislice computed tomography for the detection of coronary artery disease in diabetic patients. J Diabetes Complications 2007;21: 69-74.
16. Gowdak LH, de Paula FJ, Cesar LA, Martinez Filho EE, Ianhez LE, Krieger EM et al. Screening for significant coronary artery disease in high-risk renal transplant candidates. Coron Artery Dis 2007;18:553-8.
17. Gaston RS, Danovitch GM, Adams PL, Wynn JJ, Merion RM, Deierhoi MH et al. The report of a national conference on the wait list for kidney transplantation. Am J Transplant 2003;3:775-85.
18. McFalls EO, Ward HB, Krupski WC, Goldman S, Littooy F, Eagle K et al. Prophylactic coronary artery revascularization for elective vascular surgery: study design. Veterans Affairs Cooperative Study Group on Coronary Artery Revascularization Prophylaxis for Elective Vascular Surgery. Control Clin Trials 1999;20:297-308.
19. McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004;351: 2795-804.
20. Grundmann R, Kindler J, Meider G, Stowe H, Sieberth HG, Pichlmaier H. Dopamine treatment of human cadaver kidney graft recipients: a prospectively randomized trial. Klin Wochenschr 1982;60:193-7.
21. Carmellini M, Romagnoli J, Giulianotti PC, Pietrabissa A, Di Stefano R, Rindi P et al. Dopamine lowers the incidence of delayed graft function in transplanted kidney patients treated with cyclosporine A. Transplant Proc 1994;26:2626-9.
22. Kadieva VS, Friedman L, Margolius LP, Jackson SA, Morrell DF. The effect of dopamine on graft function in patients undergoing renal transplantation. Anesth Analg 1993;76: 362-5.
23. Sandberg J, Tyden G, Groth CG. Low-dose dopamine infusion following cadaveric renal transplantation: no effect on the incidence of ATN. Transplant Proc 1992;24:357.
24. Spicer ST, Gruenewald S, O'Connell PJ, Chapman JR, Nankivell BJ. Low-dose dopamine after kidney transplantation: assessment by Doppler ultrasound. Clin Transplant 1999;13:479-83.
25. Zacharias M, Conlon NP, Herbison GP, Sivalingam P, Walker RJ, Hovhannisyan K. Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev 2008;CD003590.
26. Kheterpal S, Tremper KK, Englesbe MJ, O'Reilly M, Shanks AM, Fetterman DM et al. Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology 2007;107: 892-902.
27. Brienza N, Giglio MT, Marucci M, Fiore T. Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study. Crit Care Med 2009;37:2079-90.
28. O'Malley CM, Frumento RJ, Bennett-Guerrero E. Intravenous fluid therapy in renal transplant recipients: results of a US survey. Transplant Proc 2002;34:3142-5.
29. O'Malley CM, Frumento RJ, Hardy MA, Benvenisty AI, Brentjens TE, Mercer JS et al. A randomized, double-blind comparison of lactated Ringer's solution and 0.9% NaCl during renal transplantation. Anesth Analg 2005;100:1518-24.
30. Hadimioglu N, Saadawy I, Saglam T, Ertug Z, Dinckan A. The effect of different crystalloid solutions on acid-base balance and early kidney function after kidney transplantation. Anesth Analg 2008;107:264-9.
31. De Gasperi A, Narcisi S, Mazza E, Bettinelli L, Pavani M, Perrone L et al. Perioperative fluid management in kidney transplantation: is volume overload still mandatory for graft function? Transplant Proc 2006;38:807-9.
32. Health Resources and Services Administration HSB, Division of Transplantation: 2007 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1997-2006. Rockville, MD, 2007.
33. Austin MT, Poulose BK, Ray WA, Arbogast PG, Feurer ID, Pinson CW. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality? Arch Surg 2007;142:1079-85.
34. Diedrich DA, Findlay JY, Harrison BA, Rosen CB. Influence of coronary artery disease on outcomes after liver transplantation. Transplant Proc 2008;40:3554-7.
35. Della Rocca G, Costa MG, Pompei L, Chiarandini P. The liver transplant recipient with cardiac disease. Transplant Proc 2008;40:1172-4.
36. Carey WD, Dumot JA, Pimentel RR, Barnes DS, Hobbs RE, Henderson JM et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 1995;59:859-64.
37. Tiukinhoy-Laing SD, Rossi JS, Bayram M, De Luca L, Gafoor S, Blei A et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol 2006;98:178-81.
38. Ripoll C, Catalina MV, Yotti R, Olmedilla L, Perez-Pena J, Lo Iacono O et al. Cardiac dysfunction during liver transplantation: incidence and preoperative predictors. Transplantation 2008;85:1766-72.
39. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007;116:1971-96.
40. Newsome LT, Weller RS, Gerancher JC, Kutcher MA, Royster RL. Coronary artery stents: II. Perioperative considerations and management. Anesth Analg 2008;107:570-90.
41. Axelrod D, Koffron A, Dewolf A, Baker A, Fryer J, Baker T et al. Safety and efficacy of combined orthotopic liver transplantation and coronary artery bypass grafting. Liver Transpl 2004;10:1386-90.
42. Tsutsui JM, Mukherjee S, Elhendy A, Xie F, Lyden ER, O'Leary E et al. Value of dobutamine stress myocardial contrast perfusion echocardiography in patients with advanced liver disease. Liver Transpl 2006;12:592-9.
43. Umphrey LG, Hurst RT, Eleid MF, Lee KS, Reuss CS, Hentz JG et al. Preoperative dobutamine stress echocardiographic findings and subsequent short-term adverse cardiac events after orthotopic liver transplantation. Liver Transpl 2008;14:886-92.
44. Zoghbi GJ, Patel AD, Ershadi RE, Heo J, Bynon JS, Iskandrian AE. Usefulness of preoperative stress perfusion imaging in predicting prognosis after liver transplantation. Am J Cardiol 2003;92:1066-71.
45. Davidson CJ, Gheorghiade M, Flaherty JD, Elliot MD, Reddy SP, Wang NC et al. Predictive value of stress myocardial perfusion imaging in liver transplant candidates. Am J Cardiol 2002;89:359-60.
46. Fili D, Vizzini G, Biondo D, Pietrosi G, Volpes R, Palazzo U et al. Clinical burden of screening asymptomatic patients for coronary artery disease prior to liver transplantation. Am J Transplant 2009;9:1151-7.
47. de Boer MT, Christensen MC, Asmussen M, van der Hilst CS, Hendriks HG, Slooff MJ et al. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg 2008;106:32-44.
48. Farrar RP, Hanto DW, Flye MW, Chaplin H. Blood component use in orthotopic liver transplantation. Transfusion 1988;28:474-8.
49. Schroeder RA, Collins BH, Tuttle-Newhall E, Robertson K, Plotkin J, Johnson LB et al. Intraoperative fluid management during orthotopic liver transplantation. J Cardiothorac Vasc Anesth 2004;18:438-41.
50. Massicotte L, Lenis S, Thibeault L, Sassine MP, Seal RF, Roy A. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl 2006;12:117-23.
51. Ozier Y, Pessione F, Samain E, Courtois F. Institutional variability in transfusion practice for liver transplantation. Anesth Analg 2003;97:671-9.
52. Ozier Y, Steib A, Ickx B, Nathan N, Derlon A, Guay J et al. Haemostatic disorders during liver transplantation. Eur J Anaesthesiol 2001;18:208-18.
53. Warnaar N, Mallett SV, de Boer MT, Rolando N, Burroughs AK, Nijsten MW et al. The impact of aprotinin on renal function after liver transplantation: an analysis of 1,043 patients. Am J Transplant 2007;7:2378-87.
54. Molenaar IQ, Warnaar N, Groen H, Tenvergert EM, Slooff MJ, Porte RJ. Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. Am J Transplant 2007;7:185-94.
55. Lodge JP, Jonas S, Jones RM, Olausson M, Mir-Pallardo J, Soefelt S et al. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transpl 2005;11:973-9.
56. Planinsic RM, van der Meer J, Testa G, Grande L, Candela A, Porte RJ et al. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl 2005;11:895-900.
57. Niemann CU, Behrends M, Quan D, Eilers H, Gropper MA, Roberts JP et al. Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores. Transfus Med 2006;16:93-100.
58. de Boer MT, Molenaar IQ, Hendriks HG, Slooff MJ, Porte RJ. Minimizing blood loss in liver transplantation: progress through research and evolution of techniques. Dig Surg 2005;22:265-75.
59. Massicotte L, Lenis S, Thibeault L, Sassine MP, Seal RF, Roy A. Reduction of blood product transfusions during liver transplantation. Can J Anaesth 2005;52:545-6.
60. Boyd SD, Stenard F, Lee DK, Goodnough LT, Esquivel CO, Fontaine MJ. Alloimmunization to red blood cell antigens affects clinical outcomes in liver transplant patients. Liver Transpl 2007;13:1654-61.
61. Schumann R. Intraoperative resource utilization in anesthesia for liver transplantation in the United States: a survey. Anesth Analg 2003;97:21-8.
62. Walia et al. Abstract O-59. 15th Annual International Liver Transplant Society; New York, NY, USA; 2009 July 8th-11th.
63. Abstract O-59. 15th Annual International Liver Transplant Society; New York, NY, USA; 2009 July 8th-11th.
64. Mandell MS, Lezotte D, Kam I, Zamudio S. Reduced use of intensive care after liver transplantation: Patient attributes that determine early transfer to surgical wards. Liver Transpl 2002;8:682-7.
65. Mandell MS, Lezotte D, Kam I, Zamudio S. Reduced use of intensive care after liver transplantation: Influence of early extubation. Liver Transpl 2002;8:676-81.
66. Glanemann M, Busch T, Neuhaus P, Kaisers U. Fast tracking in liver transplantation. Immediate postoperative tracheal extubation: feasibility and clinical impact. Swiss Med Wkly 2007;137:187-91.
67. Biancofiore G, Bindi ML, Romanelli AM, Boldrini A, Bisa M, Esposito M et al. Fast track in liver transplantation: 5 years' experience. Eur J Anaesthesiol 2005;22:584-90.
68. Mandell MS, Lockrem J, Kelley SD. Immediate tracheal extubation after liver transplantation: experience of two transplant centers. Anesth Analg 1997;84:249-53.
69. Mandell MS, Stoner TJ, Barnett R, Shaked A, Bellamy M, Biancofiore G et al. A multicenter evaluation of safety of early extubation in liver transplant recipients. Liver Transpl 2007;13:1557-63.